New Full Length from A&R: A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial of Obexelimab in Systemic Lupus Erythematosus with Exploration of Response Based on Gene Pathway Co-Expression Patterns https://t.co/5pzBfiZaNt Created with https://t.co/L5O6lHuNSY https://t.co/HvDy4b1Bg3